Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling.

Slides:



Advertisements
Similar presentations
The SWPER index for women's empowerment in Africa: development and validation of an index based on survey data  Fernanda Ewerling, MSc, Prof John W Lynch,
Advertisements

Effects of vector-control interventions on changes in risk of malaria parasitaemia in sub- Saharan Africa: a spatial and temporal analysis  Federica Giardina,
Volume 17, Issue 2, Pages (March 2014)
Volume 4, Issue 10, Pages e465-e474 (October 2017)
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and.
Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a.
Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis  Kerryn A Moore, MSc, Prof Julie.
Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis  Britt McKinnon, MSc, Sam Harper, PhD, Prof.
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling.
Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial  Dr Kirti Iyengar,
Prevalence of symptoms of vaginal fistula in 19 sub-Saharan Africa countries: a meta- analysis of national household survey data  Mathieu Maheu-Giroux,
Estimating trends in life expectancy in HIV-positive individuals
A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model  Wouter Hogendoorn, MD, M.G. Myriam.
Volume 4, Issue 10, Pages e465-e474 (October 2017)
SubbaRao M Gavaravarapu, Katherine C Smith, Rajiv N Rimal 
Volume 2, Issue 4, Pages e159-e168 (April 2015)
Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment  Jan-Walter De Neve, MD, Günther Fink, PhD, S.
Mapping HIV epidemics in sub-Saharan Africa with use of GPS data
Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data  Dr Anna Maria van Eijk, MD,
Self-assessment of the outcome of early medical abortion versus clinic follow-up in India: a randomised, controlled, non-inferiority trial  Dr Kirti Iyengar,
Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment  Dr Vittal Mogasale,
Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis  Dr Ana Requena-Méndez,
National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis  Shannon Lange,
Tackling stigma: fundamental to an AIDS-free future
Equity in antenatal care quality: an analysis of 91 national household surveys  Catherine Arsenault, PhD, Keely Jordan, MSc, Dennis Lee, BA, Girmaye Dinsa,
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis  Elima Jedy-Agba, MD, Valerie McCormack, PhD, Prof Clement.
Volume 392, Issue 10146, Pages (August 2018)
Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review.
Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003–12  Victoria Y.
Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis  Cynthia Chen, PhD, Francisco Cervero Liceras, MSc, Stefan.
Health consequences of exposure to e-waste: a systematic review
Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis  Britt McKinnon, MSc, Sam Harper, PhD, Prof.
Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness.
Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study  Zafar Zafari, BSc, MSc, Larry.
Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study  Nick.
Valuing innovative endoscopic techniques: per-oral endoscopic myotomy for the management of achalasia  Eric D. Shah, MD, MBA, Andrew C. Chang, MD, Ryan.
Mortality risks in children aged 5–14 years in low-income and middle-income countries: a systematic empirical analysis  Prof Kenneth Hill, PhD, Linnea.
Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis  Dr Shevanthi Nayagam,
Effects of health-system strengthening on under-5, infant, and neonatal mortality: 11- year provincial-level time-series analyses in Mozambique  Quinhas.
Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study  Dr Patrick.
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
Cost and cost-effectiveness of newborn home visits: findings from the Newhints cluster- randomised controlled trial in rural Ghana  Catherine Pitt, MSc,
Effects of vector-control interventions on changes in risk of malaria parasitaemia in sub- Saharan Africa: a spatial and temporal analysis  Federica Giardina,
Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)
The SWPER index for women's empowerment in Africa: development and validation of an index based on survey data  Fernanda Ewerling, MSc, Prof John W Lynch,
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling.
Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real- world cost analysis and economic evaluation  Prof Anna Vassall,
Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a.
Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study  Sabin Nsanzimana, MD, Eric Remera, MSc, Steve Kanters,
Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India  Dr Anna Vassall, PhD,
Age-specific and sex-specific adult mortality risk in India in 2014: analysis of 0·27 million nationally surveyed deaths and demographic estimates from.
Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis 
Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis  Chunqing Lin,
Age-specific and sex-specific adult mortality risk in India in 2014: analysis of 0·27 million nationally surveyed deaths and demographic estimates from.
Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial  Thomas Lung, PhD, Guy.
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated.
Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people.
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation 
The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study 
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and.
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Asthma in Japan and the Value of Responder Prediction Methods Based on a Multinational.
Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya  John Ojal, PhD, Ulla Griffiths,
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost- effectiveness analysis  Mark D. Schleinitz, MS, MD, J.Peter Weiss, MS,
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy.
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer  Thibaut Lizée, MD, Ethan Basch, MD, MSc, Pierre Trémolières,
Use of standardised patients to assess gender differences in quality of tuberculosis care in urban India: a two-city, cross-sectional study  Benjamin.
Cost-effectiveness acceptability curves (CEAC) of tight control versus clinical management excluding (base case) and including absenteeism due to Crohn’s.
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a.
Presentation transcript:

Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data  Silke Fernandes, MSc, Elisa Sicuri, PhD, Kassoum Kayentao, MD, Anne Maria van Eijk, PhD, Jenny Hill, PhD, Jayne Webster, PhD, Vincent Were, MSc, James Akazili, PhD, Mwayi Madanitsa, MD, Prof Feiko O ter Kuile, PhD, Prof Kara Hanson, ScD  The Lancet Global Health  Volume 3, Issue 3, Pages e143-e153 (March 2015) DOI: 10.1016/S2214-109X(14)70385-7 Copyright © 2015 Fernandes et al. Open Access article distributed under the terms of CC BY-NC-SA Terms and Conditions

Figure 1 The decision tree The decision tree model shows the example for LBW. All numbers are the results published by Kayentao and colleagues.10 The example shown here is representative of a setting with moderate LBW risk and included all pregnant women independent of HIV status (positive, negative, unknown). The same structure was used for severe anaemia and clinical malaria. LBW=low birthweight. IPTp-SP=intermittent preventive treatment with sulfadoxine-pyrimethamine. SP2=two doses of IPTp-SP during pregnancy. SP3+=three or more doses of IPTp-SP during pregnancy. G1/G2=women who have had one or two pregnancies. G3+=women who have had three or more pregnancies. The Lancet Global Health 2015 3, e143-e153DOI: (10.1016/S2214-109X(14)70385-7) Copyright © 2015 Fernandes et al. Open Access article distributed under the terms of CC BY-NC-SA Terms and Conditions

Figure 2 Tornado diagram—deterministic sensitivity analysis The variable ranges imputed for each variable are shown in parentheses. The light green bars show the direction and magnitude of change in the incremental cost-effectiveness ratio, when the input variable is set to its minimum value; the dark green bars show the direction and magnitude of change when the input variable is set to its maximum. See appendix for more information. ANC=antenatal care. DALY=disability-adjusted life-years. G1/G2=Women who have had one or two pregnancies. G3+=women who have had three or more pregnancies. IPTp-SP=intermittent preventive treatment with sulfadoxine-pyrimethamine. SP=sulfadoxine-pyrimethamine. SP2=two doses of IPTp-SP during pregnancy. SP3+=three or more doses of IPTp-SP during pregnancy. *Relative risk capped at one, see methods and appendix.. The Lancet Global Health 2015 3, e143-e153DOI: (10.1016/S2214-109X(14)70385-7) Copyright © 2015 Fernandes et al. Open Access article distributed under the terms of CC BY-NC-SA Terms and Conditions

Figure 3 Cost-effectiveness planes The graphs show the results of four different Monte Carlo Simulations with 10 000 iterations each using the value ranges and distributions specified in table 2. The assumed control group risk point estimates for low birthweight in both gravidae subgroups were varied in the three scenarios, representing cost-effectiveness in moderate risk (A), low risk (B), and high risk (C) of low birthweight settings. Panel D shows the results for the simulation using input parameters reported for HIV-negative women by Kayentao and colleagues.10 For the moderate risk of low birthweight setting, we used the base case parameter values of the assumed control group risk reported by Kayentao and colleagues; for low-risk and high-risk groups we used the minimum and maximum value of the parameter range. All other values, ranges, and distributions were kept the same. WTP=willingness to pay. DALYs=disability-adjusted life-years. SP2=two doses of IPTp-SP. SP3+=three or more doses of IPTp-SP. The Lancet Global Health 2015 3, e143-e153DOI: (10.1016/S2214-109X(14)70385-7) Copyright © 2015 Fernandes et al. Open Access article distributed under the terms of CC BY-NC-SA Terms and Conditions

Figure 4 Cost-effectiveness acceptability curves The curves show the probability of three doses of intermittent preventive treatment with sulfadoxine-pyrimethamine being cost effective at any given willingness-to-pay (WTP) value for moderate (A), and low and high (B) low birthweight risk settings as well as for HIV-negative women only. The vertical lines indicate three WTP thresholds. BF=Burkina Faso. DALY=disability adjusted life year. GDP=gross domestic product. ML=Mali. MW=Malawi. KE=Kenya. TZ=Tanzania. WHO=World Health Organization. ZM=Zambia. CE=cost effective. The Lancet Global Health 2015 3, e143-e153DOI: (10.1016/S2214-109X(14)70385-7) Copyright © 2015 Fernandes et al. Open Access article distributed under the terms of CC BY-NC-SA Terms and Conditions